Our recent study on the unfolding humoral immunity to TBE-vaccination in allogeneic HSCT recipients has shown that the total number of CD4+ T-cells prior to re-vaccination was a significant predictor for neutralizing antibody production after two vaccinations [8]. This evidence concerns the gene CD4 and tick-borne encephalitis.